Dataset Information

Multi-Omics Integration Identifies Critical Molecular Drivers and Alternative Splicing Events in Small Cell Lung Cancer II

ABSTRACT: Small cell lung cancer (SCLC) remains a highly aggressive malignancy and a therapeutic challenge in clinical oncology. Here, we conducted an integrated multi-omics analysis of treatment-naïve human SCLC tissues along with paired adjacent tissues (NAT, n = 12), including transcriptomic, proteomic, phosphoproteomic, and glycoproteomic profiling to identify novel prognostic markers and therapeutic targets. Integration of these datasets revealed significant enrichment of RNA splicing pathway in SCLC. We systematically characterized aberrant alternative splicing events (AASEs), identifying 6,972 events with exon skipping representing the most prevalent type. These AASEs were regulated by RNA-binding proteins and predominantly enriched in pathways related to tumor proliferation and metastasis. We further identified four splicing-related proteins (THOC1, MAGOHB, RBM8A, and TXNL4A) that were markedly overexpressed in SCLC, correlated with proliferation, and predicted poor prognosis. Functional validation showed that THOC1 knockdown suppressed tumor growth in vivo, potentially through enhanced anti-tumor immunity. Additionally, we present the first N-glycoproteomic atlas of SCLC implicating glycosylated CEACAM proteins as potential biomarkers and revealing aberrantly glycosylated sites and proteins associated with SCLC. Our study unveils novel molecular features underlying SCLC pathogenesis and provides insights for developing therapeutic strategies targeting RNA splicing and protein glycosylation.

ORGANISM(S): Mus musculus

PROVIDER: GSE330548 | GEO | 2026/05/14

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Defects in blood development are a major contributor to complex congenital anomalies. Thrombocytopenia-Absent Radius (TAR) Syndrome is a rare congenital disease presenting with reduced blood platelets (megakaryocytic thrombocytopenia) and forelimb anomalies, concurrent with variable heart and kidney defects caused by hypomorphic RBM8A/Y14 gene function. RBM8A encodes a component of the ubiquitous exon junction complex involved in mRNA splicing, transport, and nonsense-mediated decay. How perturbing a general mRNA-processing factor causes the distinct phenotypes of TAR Syndrome remains unknown. Here, we connect zebrafish rbm8a perturbation to early hematopoiesis defects via attenuated planar cell polarity (PCP) signaling involved in controlling developmental cell arrangements. Combining different genetic means to reduce rbm8a function, we find a significant reduction of cd41-positive thrombocytes in hypomorphic rbm8a larvae. Transcriptomics analysis documents rbm8a-mutant zebrafish embryos already after gastrulation accumulate mRNAs with erroneously included introns, a hallmark of defective nonsense-mediated decay. Affected mRNAs include transcripts encoding components of the non-canonical Wnt pathway involved in PCP signaling, and rbm8a mutant-embryos show hallmarks of Wnt/PCP-dependent, early convergent extension defects. We establish that reduced rbm8a function synergizes with perturbations in Wnt/PCP pathway genes including wnt5b, wnt11f2, fzd7a, and vangl2. Following axis formation, rbm8a perturbation impairs the migration and architecture of the lateral plate mesoderm (LPM) that forms the hematopoietic, cardiovascular, kidney, and forelimb skeleton progenitors. Subsequently, rbm8a perturbation impairs expression of early hematopoietic/endothelial genes including runx1a, kdrl, sox7, and the megakaryocyte regulator gfi1aa. Lastly, we document similar hematopoietic defects upon loss of vangl2. Together, our data link reduced rbm8a function to LPM migration and hematopoietic defects via attenuated Wnt/PCP signaling. Our findings establish a developmental framework that connects the complex TAR Syndrome phenotypes to a potential LPM origin.

Project description:The craniofacial developmental disorder Burn-McKeown Syndrome (BMKS) is caused by biallelic variants in the pre-messenger RNA splicing factor gene TXNL4A/DIB1. The majority of affected individuals with BMKS have a 34 base pair deletion in the promoter region of one allele of TXNL4A combined with a loss-of-function variant on the other allele, resulting in reduced TXNL4A expression. However, it is unclear how reduced expression of this ubiquitously expressed spliceosome protein results in craniofacial defects during development. Here we reprogrammed peripheral mononuclear blood cells from a BMKS patient and her unaffected mother into induced pluripotent stem cells (iPSCs) and differentiated the iPSCs into induced neural crest cells (iNCCs), the key cell type required for correct craniofacial development. BMKS patient-derived iPSCs proliferated more slowly than both mother- and unrelated control-derived iPSCs, and RNA-Seq analysis revealed significant differences in gene expression and alternative splicing. Patient iPSCs displayed defective differentiation into iNCCs compared to maternal and unrelated control iPSCs, in particular a delay in undergoing an epithelial-to-mesenchymal transition (EMT). RNA-Seq analysis of differentiated iNCCs revealed widespread gene expression changes and mis-splicing in genes relevant to craniofacial and embryonic development that highlight a dampened response to WNT signalling, the key pathway activated during iNCC differentiation. Furthermore, we identified the mis-splicing of TCF7L2 exon 4, a key gene in the WNT pathway, as a potential cause of the downregulated WNT response in patient cells. Additionally, mis-spliced genes shared common physical properties such as length, splice site strengths and sequence motifs, suggesting that splicing of particular subsets of genes is particularly sensitive to changes in TXNL4A expression. Together, these data provide the first insight into how reduced TXNL4A expression in BMKS patients might compromise splicing and NCC function, resulting in defective craniofacial development in the embryo.

Dataset Information

Multi-Omics Integration Identifies Critical Molecular Drivers and Alternative Splicing Events in Small Cell Lung Cancer II

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets